Internal Medicine, Pulmonary Disease · Silvis, IL
NPI
1598961658
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
855 Illini Dr, Ste 305
Silvis, IL, 61282
Phone (309) 792-4930
Groups this clinician bills Medicare through
Medicare paid, 2024
$88K
1,302 services
Medicare patients, 2024
349
Average age 75
Drug cost, 2024
$1.7M
3,420 prescriptions
Company payments, 2025
$857
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Magdy Mostafa was code 99214 (office e&m - established), 378 times for 206 patients. In total Magdy Mostafa billed 1,302 services in 28 codes, and Medicare paid $88K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 378 | 206 | $86.25 | $33K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 131 | 113 | $12.51 | $1,639 |
| 99232 Hospital E&M - Subsequent | Facility | 91 | 32 | $60.62 | $5,517 |
| G0008 Administration of influenza virus vaccine | Office | 70 | 70 | $31.15 | $2,181 |
| 94729 Pulmonary Function Testing | Facility | 64 | 64 | $6.58 | $421 |
| G0009 Administration of pneumococcal vaccine | Office | 63 | 63 | $30.66 | $1,931 |
| 94726 Pulmonary Function Testing | Facility | 63 | 63 | $8.82 | $556 |
| 90677 Vaccine Product | Office | 63 | 63 | $286.86 | $18K |
| 90653 Vaccine Product | Office | 61 | 61 | $81.82 | $4,991 |
| 94060 Pulmonary Function Testing | Facility | 54 | 54 | $7.59 | $410 |
| 99233 Hospital E&M - Subsequent | Facility | 48 | 17 | $90.87 | $4,362 |
| 99213 Office E&M - Established | Office | 40 | 34 | $58.94 | $2,358 |
| 99204 Office E&M - New | Office | 22 | 22 | $122.36 | $2,692 |
| 99231 Hospital E&M - Subsequent | Facility | 22 | 15 | $38.25 | $841 |
| 99223 Hospital E&M - Initial | Facility | 21 | 20 | $133.03 | $2,794 |
By year: 2022 $76K for 1,388 services; 2023 $76K for 1,380 services; 2024 $88K for 1,302 services.
Medicare prescription drug claims, 2024
In 2024, the drug Magdy Mostafa prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 591 prescriptions and refills. In total Magdy Mostafa wrote 3,420 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 591 | 747 | 96 | $477K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 480 | 536 | 140 | $12K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 466 | 562 | 76 | $260K |
| Breo Ellipta Fluticasone/Vilanterol | 334 | 435 | 64 | $171K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 176 | 225 | 35 | $140K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 160 | 204 | 37 | $97K |
| Spiriva Respimat Tiotropium Bromide | 155 | 206 | 34 | $109K |
| Incruse Ellipta Umeclidinium Bromide | 138 | 166 | 20 | $58K |
| Azithromycin Generic | 115 | 131 | 41 | $1,583 |
| Symbicort Budesonide/Formoterol Fumarate | 86 | 94 | 19 | $22K |
| Prednisone Generic | 83 | 92 | 42 | $323 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 80 | 104 | 16 | $9,668 |
| Fluticasone Propionate Generic | 72 | 140 | 28 | $705 |
| Bevespi Aerosphere Glycopyrrolate/Formoterol Fum | 61 | 67 | 16 | $27K |
| Ventolin Hfa Albuterol Sulfate | 60 | 70 | 23 | $4,095 |
Brand drugs: 2,643 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Magdy Mostafa $857 ($857 in general payments such as food, travel and fees) from 13 companies. The largest payer was GlaxoSmithKline, LLC. with $254.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 18 | $254 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $197 |
| Insmed, Inc. INSM | 4 | $75.78 |
| Verona Pharma, Inc. VRNA | 1 | $57.85 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $53.44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48.89 |
| Lilly USA, LLC LLY | 2 | $34.74 |
| Baxter Healthcare BAX | 1 | $28.03 |
| Grifols USA, LLC | 1 | $25.72 |
| Harmony Biosciences LLC HRMY | 1 | $24.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.